Diagonal Bio AB has signed a distribution agreement with Techtum Lab AB
RegulatoryDiagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) has signed a distribution agreement with Techtum Lab AB (“Techtum Lab”). Techtum Lab is granted the rights to distribute Diagonal Bio’s analytical instrument, LAMPlify®, in Sweden until May 30, 2025, with an option for a 12-month renewal. This collaboration was initiated by a first critical milestone in the pilot study which started in November 2023.
Read more